Best Seller

Mouse CD45 Antibody

R&D Systems | Catalog # AF114

R&D Systems

Key Product Details

Species Reactivity

Validated:

Mouse

Cited:

Human, Mouse, Rat, Transgenic Mouse

Applications

Validated:

Immunohistochemistry, Western Blot, Flow Cytometry, Immunocytochemistry, CyTOF-ready

Cited:

Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Western Blot, Flow Cytometry, Immunocytochemistry, Cell Selection, IF/ICC

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG
Loading...

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant mouse CD45
Gln24-Lys425
Accession # NP_035340

Specificity

Detects mouse CD45 in direct ELISAs and Western blots.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Scientific Data Images for Mouse CD45 Antibody

CD45 in RAW 264.7 Mouse Cell Line.

CD45 was detected in immersion fixed RAW 264.7 mouse monocyte/macrophage cell line (positive staining) and Neuro‑2A mouse neuroblastoma cell line (negative staining) using Goat Anti-Mouse CD45 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF114) at 5 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; NL001) and counterstained with DAPI (blue). Specific staining was localized to cell surface. Staining was performed using our protocol for Fluorescent ICC Staining of Non-adherent Cells.
CD45 antibody in Mouse Liver by Immunohistochemistry (IHC-P).

CD45 in Mouse Liver.

CD45 was detected in immersion fixed paraffin-embedded sections of mouse liver using Goat Anti-Mouse CD45 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF114) at 3 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Goat IgG VisUCyte™ HRP Polymer Antibody (VC004). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (CTS013). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to Kupffer cells. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.
Detection of Mouse CD45 by Immunocytochemistry/Immunofluorescence

Detection of Mouse CD45 by Immunocytochemistry/Immunofluorescence

The recruitment of CD45+F4/80+CD68+ macrophages was similar in the ASC-seeded DAT scaffolds that were cultured dynamically and statically for 14 days prior to implantation in the nu/nu mouse model. (A) Representative images showing CD45 (cyan), F4/80 (red), and CD68 (green) expression with DAPI counterstaining (blue) at 1-week post-implantation. Scale bars represent 100 μm. Boxed regions in the composite images are shown at higher magnification below. White arrowheads highlight CD45+F4/80+CD68+DAPI+ cells. (B) CD45+F4/80+CD68+DAPI+ cell density in the static and dynamic groups. (C) The percentage of CD45+F4/80+CD68+DAPI+ cells relative to the total CD45+DAPI+ cell population at 1, 4, and 8 weeks. *p < 0.05, **p < 0.01, ***p < 0.001. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33816453), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Tizaterkib treatment lowers the number of CD45-positive cells in the cochlea 4 days post noise exposure. (A) Representative low-magnification images of cochlear cryosections stained with CD45 (red) and DAPI (blue). The treatment protocol shown in Figure 2A was utilized and mice were sacrificed 4 days after noise exposure, 1 h after the final tizaterkib treatment. (B) Quantification of the CD45-positive cells in the cochlear sections in (A). (C) Higher magnification of the images shown in (A) of the scala tympani. (D) Quantification of CD45-positive cells in the walls of the scala tympani as presented in (C). (E) Representative images of cochlear cryosections of the stria vascularis following noise and tizaterkib treatment. (F) Quantification of CD45-positive cells per experimental group from the images in (E). Carrier (black), tizaterkib alone (blue), noise alone (red), noise + tizaterkib (green). Data shown as means ± SEM, * p < 0.05 and *** p < 0.001 compared to noise alone by one-way ANOVA with a Bonferroni post hoc test. n = 3–6 mice, with 3 sections each per mouse. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/38928015), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Therapeutic potential of NLRP3 inhibition in the progression of nocturnal NIHL. A–C ABR thresholds were measured 14 days after DNE and NNE, comparing the CY-09-treated group and the control group. Grey shading indicates the range of noise frequencies. Data are presented as the mean ± SD, replicated across four independent noise exposures per group (n = 9 for DMSO-DNE, n = 7 for CY-09-DNE, n = 9 for DMSO-NNE, and n = 9 for CY-09-NNE; **P < 0.01, ***P < 0.001, ****P < 0.0001, two-way ANOVA, Bonferroni post hoc test). D Representative confocal images of CD45 (green) and CD68 (pink)-stained macrophages in the BM at 3 days after DNE and NNE. Scale bars, 100 μm. E Numbers of CD45+CD68+ cells in the BM at 3 days after DNE and NNE. Data are presented as the mean ± SD from 3 mice per group, replicated across three independent noise exposures (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, one-way ANOVA, Bonferroni post hoc test). F, G Representative western blots and statistical analysis of pro-caspase-1, IL-1 beta, and IL-18 protein expression at 3 days after DNE and NNE. Protein levels are normalized to ACTB. Data are presented as the mean ± SD from 3–6 mice per group, replicated across three independent noise exposures (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, one-way ANOVA, Bonferroni post hoc test). Image collected and cropped by CiteAb from the following open publication (https://link.springer.com/10.1007/s12264-025-01440-1), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Characterization of CD34+ cells in transplant arteriosclerosis. (A) The schematic diagram of arterial graft model (left); Zone map for grafted artery segment (middle); An overview of the in vivo experiment strategy (right). (B) The whole-mount immunostaining of CD34 in normal thoracic aortas (n = 6), isografts (n = 6) and allografts (n = 6). (C) The en-face immunostaining of CD34 in normal thoracic aortas (n = 6), isografts (n = 6) and allografts (n = 6). (D)Representative immunostaining images of CD34 on cryosections from normal thoracic aortas (n = 6), isografts (n = 6) and allografts (n = 6). (E) Representative HE staining images from normal thoracic aortas (n = 6), isografts (n = 6) and allografts (n = 6). (F-I) Representative co-immunofluorescence images of CD34 and the endothelial cell marker CD31, smooth muscle cell marker alpha -SMA ( alpha -smooth muscle actin), fibrotic cell marker PDGFR-alpha (platelet-derived growth factor receptor alpha ), and inflammatory cell marker CD45 in 4-week grafted arteries (n = 8). Nuclei were counterstained with DAPI. (J) Semi-quantification of the percentage of CD34+ cells that express CD31, alpha -SMA, PDGFR-alpha and CD45. Data were presented as the mean ± SEM. (K) Flow cytometry analysis of the proportion of CD31, alpha -SMA, PDGFR-alpha and CD45 positive cells expressing CD34 in 4-week grafted arteries (n = 6). (L) Cartoon image showing that CD34+ cells include a subset of endothelial cells (ECs), adventitial stem/progenitor cells (adSPCs), CD45+ cells and fibroblasts (FBs). Image collected and cropped by CiteAb from the following open publication (https://www.thno.org/v15p2523.htm), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Tizaterkib treatment lowers the number of CD45-positive cells in the cochlea 4 days post noise exposure. (A) Representative low-magnification images of cochlear cryosections stained with CD45 (red) and DAPI (blue). The treatment protocol shown in Figure 2A was utilized and mice were sacrificed 4 days after noise exposure, 1 h after the final tizaterkib treatment. (B) Quantification of the CD45-positive cells in the cochlear sections in (A). (C) Higher magnification of the images shown in (A) of the scala tympani. (D) Quantification of CD45-positive cells in the walls of the scala tympani as presented in (C). (E) Representative images of cochlear cryosections of the stria vascularis following noise and tizaterkib treatment. (F) Quantification of CD45-positive cells per experimental group from the images in (E). Carrier (black), tizaterkib alone (blue), noise alone (red), noise + tizaterkib (green). Data shown as means ± SEM, * p < 0.05 and *** p < 0.001 compared to noise alone by one-way ANOVA with a Bonferroni post hoc test. n = 3–6 mice, with 3 sections each per mouse. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/38928015), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Pharmacological inhibition of IL12 beta attenuated TAC-induced pulmonary inflammation. (A, B) Representative images and quantified data of infiltrated CD45+ leukocytes in the lung performed by immuno-histological staining. (C) The percentage of immune cell subsets within CD45+ leukocytes. (D) The percentage of different macrophage subsets within F4/80 macrophages. (E) The percentage of immune cell subsets within CD3+ T cells. *p<0.05; #p<0.05 IgG-treated TAC mice compared with the control; †p<0.05 anti-IL12 beta -treated TAC mice compared with IgG-treated TAC mice; $p<0.05 anti-IL12 beta -treated TAC mice compared with the control; Mφ, Macrophage; DCs, Dendritic Cells; NK, Natural Killer Cells; AMφ, Alveolar Mφ; IMφ, Interstitial Mφ; MdMφ, Monocyte-derived Mφ; NKT, Natural Killer T Cells; n = 4–5 mice per group. Image collected and cropped by CiteAb from the following open publication (https://www.frontiersin.org/articles/10.3389/fimmu.2025.1624940/full), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Distribution of CD45+ macrophages in different group. The mice were injected subcutaneously with tamoxifen (TMX) at P0 and P1 and injected with AAV2.7m8‐gfaABC1D‐Gjb2 (5 × 109 genome‐containing (particles) (GCs) per ear) at P2. Dexamethasone was administered to mice at a dose of 3 mg kg−1 every two days starting at P10‐24. All of the mice were tested for auditory brainstem response (ABR) and sacrificed at P24–P25. A) Immunofluorescent staining of CD45+ macrophages (green) in the apex, middle and base turns of different groups. White: F‐actin. Scale bars = 30 µm. B,C) Statistics of CD45+ cell number and macrophage size in different groups. Data are shown as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. ns: non‐significant. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39739601), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Western Blot

Detection of CD45 by Western Blot

Tizaterkib treatment lowers the amount of CD45 and CD68 in the cochlea 6 days post noise exposure. (A) Western blots showing the amount of CD45 and CD68 in the cochlea following noise exposure and tizaterkib treatment. The same treatment protocol shown in Figure 2A was utilized and mice were sacrificed 6 days after noise exposure. (B) CD45/GAPDH ratio, normalized to the carrier-alone lane. Band intensities were measured using ImageJ software (version 1.54g). (C) CD68/GAPDH ratio, normalized to the carrier-alone lane. Data shown as means ± SEM, * p < 0.05 and ** p < 0.01 compared to noise alone by one-way ANOVA with a Bonferroni post hoc test. The experimental groups, from left to right, are as follows: carrier alone, tizaterkib alone, noise alone, and noise + tizaterkib. Each group had the cochleae from 5 mice (10 cochleae) pooled together to make the tissue lysate. n = 5. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/38928015), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Loss of RGS2 or RGS5 increases immune cell presence in ventricular tissue. Representative CD45 labeling (brown) (a, quantified in b (n = 8 hearts)) and CD68 labeling (c, quantified in d (n = 4–5 hearts)) demonstrates increased immune cell infiltration in saline‐treated Rgs2 and Rgs5 KO ventricular tissue. Symbols in the graphs represent individual samples from separate animals. Data in the summarized plots are mean ± standard deviation. Two‐way ANOVA mixed model, with Šidák post hoc analysis, was applied for multiple comparisons for statistical significance. Stated numbers in the graphs are p‐values for individual comparisons. SAL, saline; ISO, isoproterenol. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39746869), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

IL-12 alpha KO significantly attenuated TAC-induced pulmonary inflammation, fibrosis, and vessel remodeling. (A–D) Representative images and quantified data of infiltrating leukocytes or macrophages in the lung performed by immuno-histological staining. (E, F) Representative images and quantified data of lung fibrosis performed by Sirius red/Fast green staining. (G, H) Representative images and quantified data of pulmonary vessel remodeling performed by immuno-histological staining. (I–L) Alterations of MCP1, IL-6, IL-1 alpha, and IL-1 beta per lungs sample. *p<0.05; ns, non-significant. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36860846), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Representative scanning electron microscopy and immunofluorescence showed recruitment of different immune cell subsets at CCM lesions in the cerebellum of the Ccm3iECKO mice at P28 for chronic CCM. A Leukocytes are attached to the endothelial cells of CCM lesions in chronic CCM. B-E Cerebellum in Ccm3iECKO mice at P28 in chronic CCM. DAPI staining (blue), together with: (B) MHC class II (green), CD45 (red) and isolectin-B4 (white); (C) Ly6g+ (green), CD45 (red) and isolectin-B4 (white); (D) F4/80 (green), CD45 (red) and isolectin-B4 (white); and (E) CD45R/B220 (red) and CD45 (white). White line in (E) shows the location of the lesions in the cerebellum; white arrows, examples of the immune cell subsets that are positive for both DAPI and CD45. Scale bars: 10 μm (A); 50 μm (B–E). Image collected and cropped by CiteAb from the following open publication (https://link.springer.com/10.1007/s00018-022-04224-2), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Macrophage recruitment and activation in response to noise exposure, particularly after NNE. A Representative confocal images of activated OSL macrophages in the middle turn of cochleae at pre-exposure days 1, 3, 7, and 14 (Ctrl, Ne1d, Ne3d, Ne7d, and Ne14d) after DNE and NNE. Macrophages are stained with CD45 (green) and CD68 (pink). Scale bars, 100 μm. For representative images of other OSL and BM macrophages, see also Fig. S3A–J. B Quantification of CD45+CD68+ macrophages in the OSL of the middle turn. Macrophage counts increase significantly after 3 days of exposure, particularly in the NNE group. Data are presented as the mean ± SD from 3 mice per group, replicated across three independent noise exposures (ns, no significant difference, *P < 0.05, two-way ANOVA, Bonferroni post hoc test). C Schematic of macrophage depletion using CLs via caudal vein injection. D–F ABR thresholds were measured 14 days after DNE and NNE, comparing CL treatment with control. Grey represents the range of noise frequencies. Data are presented as the mean ± SD, replicated across 3–4 independent noise exposures per group (*P < 0.05, two-way ANOVA, Bonferroni post hoc test, n = 10 for Ctrl-DNE, n = 10 for CL treatment-DNE, n = 11 for Ctrl-NNE, and n = 12 for CL treatment-NNE). G Representative confocal images of macrophages stained by CD68 (green) in the mid-modiolar axis at 3 days after DNE and NNE, comparing CL treatment with control. Scale bars, 100 μm. H Numbers of macrophages per section in the apical, middle, and basal turns. Data are presented as the mean ± SD from 3 mice per group, replicated across three independent noise exposures (*P < 0.05, **P < 0.01, ***P < 0.001, one-way ANOVA, Bonferroni post hoc test). Image collected and cropped by CiteAb from the following open publication (https://link.springer.com/10.1007/s12264-025-01440-1), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Flow Cytometry

Detection of CD45 by Flow Cytometry

Characterization of CD34+ cells in transplant arteriosclerosis. (A) The schematic diagram of arterial graft model (left); Zone map for grafted artery segment (middle); An overview of the in vivo experiment strategy (right). (B) The whole-mount immunostaining of CD34 in normal thoracic aortas (n = 6), isografts (n = 6) and allografts (n = 6). (C) The en-face immunostaining of CD34 in normal thoracic aortas (n = 6), isografts (n = 6) and allografts (n = 6). (D)Representative immunostaining images of CD34 on cryosections from normal thoracic aortas (n = 6), isografts (n = 6) and allografts (n = 6). (E) Representative HE staining images from normal thoracic aortas (n = 6), isografts (n = 6) and allografts (n = 6). (F-I) Representative co-immunofluorescence images of CD34 and the endothelial cell marker CD31, smooth muscle cell marker alpha -SMA ( alpha -smooth muscle actin), fibrotic cell marker PDGFR-alpha (platelet-derived growth factor receptor alpha ), and inflammatory cell marker CD45 in 4-week grafted arteries (n = 8). Nuclei were counterstained with DAPI. (J) Semi-quantification of the percentage of CD34+ cells that express CD31, alpha -SMA, PDGFR-alpha and CD45. Data were presented as the mean ± SEM. (K) Flow cytometry analysis of the proportion of CD31, alpha -SMA, PDGFR-alpha and CD45 positive cells expressing CD34 in 4-week grafted arteries (n = 6). (L) Cartoon image showing that CD34+ cells include a subset of endothelial cells (ECs), adventitial stem/progenitor cells (adSPCs), CD45+ cells and fibroblasts (FBs). Image collected and cropped by CiteAb from the following open publication (https://www.thno.org/v15p2523.htm), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Arterial CD34+ cells affect neointimal hyperplasia in the development of allograft arteriosclerosis. (A) Schematic showing genetic lineage tracing by CD34-CreERT2; Rosa26-tdTomato; iDTR. (B) Representative immunofluorescence images of tdT+ cells from cryosections of CD34-CreERT2; Rosa26-tdTomato; iDTR mice treated with (n = 6) or without (n = 6) DT. (C) Representative co-immunofluorescence images of tdTomato and CD34 in CD34-CreERT2; Rosa26-tdTomato; iDTR mice (n = 6); and semi-quantification of the percentage of tdTomato+ cells in CD34+ cells. Data were presented as the mean ± SEM. (D) Sketch of the experimental strategy. (E) Representative HE staining of grafted arteries (n = 6); and semi-quantification of neointimal area in the presence and ablation of CD34+ cells. Data were presented as the mean ± SEM and analyzed by using an unpaired two-tailed Student's t-test. (F-K) Representative co-immunofluorescence images of CD34 and PDGFR-alpha, CD31, and CD45 on cryosections from 4-week grafted arteries in the group with (n = 6) and without (n = 6) DT. (L) Semi-quantification of the percentage of PDGFR-alpha, CD31 and CD45 cells expressing tdTomato for F-K. Data were presented as the mean ± SEM and analyzed by using an unpaired two-tailed Student's t-test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. (M) Cartoon image showing that CD34+ cells repair endothelial cells and promote neointimal thickening in allograft injury. Image collected and cropped by CiteAb from the following open publication (https://www.thno.org/v15p2523.htm), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Representative scanning electron microscopy and immunofluorescence showed recruitment of different immune cell subsets at CCM lesions in the cerebellum of the Ccm3iECKO mice at P28 for chronic CCM. A Leukocytes are attached to the endothelial cells of CCM lesions in chronic CCM. B-E Cerebellum in Ccm3iECKO mice at P28 in chronic CCM. DAPI staining (blue), together with: (B) MHC class II (green), CD45 (red) and isolectin-B4 (white); (C) Ly6g+ (green), CD45 (red) and isolectin-B4 (white); (D) F4/80 (green), CD45 (red) and isolectin-B4 (white); and (E) CD45R/B220 (red) and CD45 (white). White line in (E) shows the location of the lesions in the cerebellum; white arrows, examples of the immune cell subsets that are positive for both DAPI and CD45. Scale bars: 10 μm (A); 50 μm (B–E). Image collected and cropped by CiteAb from the following open publication (https://link.springer.com/10.1007/s00018-022-04224-2), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Western Blot

Detection of CD45 by Western Blot

Pretreatment with rapamycin (RAP) attenuates the isoproterenol (ISO)‐induced necrosis in mouse hearts. A and B, Evan's blue dye (EBD) uptake assays. Mice of the control (CTL), ISO, and RAP + ISO groups were subject to an intraperitoneal injection of EBD (100 μg/g, i.p.) 6 h after the second saline or ISO injection and sacrificed 18 h later for tissue collection. The cryosections of ventricular myocardium were counterstained with DAPI (blue) and Alexa 488‐conjugated phalloidin (green) before imaged with a confocal microscope. EBD showed red auto‐fluorescence. Shown are representative confocal micrographs taken from anatomically comparable locations (a) and a graph summarizing the percentage EBD‐positive area from 4 mice per group (b). mean ± SD; n = 4 mice (3 males and 1 female) per group. (c–e) Representative images (c) and pooled densitometry data (d, e) of western blot analyses for myocardial CD45 and Galectin 3. Total myocardial protein extracts were used L.C., loading control; mean ± SD; n = 3 mice per group. p Values are derived from one‐way ANOVA followed by Tukey's test. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/38444056), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Distribution of CD45+ macrophages in AAV2.7m8‐Gjb2 injection group. Mice were injected with AAV2.7m8‐gfaABC1D‐eGFP or AAV2.7m8‐gfaABC1D‐Gjb2 (5 × 109 genome‐containing (particles) (GCs) at P2 and the cochlea was harvested at P24. Beginning at P10‐24, mice were administered dexamethasone at a dose of 3 mg kg−1 once every two days. A–D) Immunofluorescent staining of CD45+ macrophages (green) in the apical, middle, and basal turns of different groups. Blue: DAPI. White: F‐actin. Scale bars represent 200 and 30 µm, respectively. E,F) Comparison of the numbers and the macrophage size of CD45+ cells in the different groups. Data are shown as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. ns: non‐significant. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39739601), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Representative scanning electron microscopy and immunofluorescence showed recruitment of different immune cell subsets at CCM lesions in the cerebellum of the Ccm3iECKO mice at P28 for chronic CCM. A Leukocytes are attached to the endothelial cells of CCM lesions in chronic CCM. B-E Cerebellum in Ccm3iECKO mice at P28 in chronic CCM. DAPI staining (blue), together with: (B) MHC class II (green), CD45 (red) and isolectin-B4 (white); (C) Ly6g+ (green), CD45 (red) and isolectin-B4 (white); (D) F4/80 (green), CD45 (red) and isolectin-B4 (white); and (E) CD45R/B220 (red) and CD45 (white). White line in (E) shows the location of the lesions in the cerebellum; white arrows, examples of the immune cell subsets that are positive for both DAPI and CD45. Scale bars: 10 μm (A); 50 μm (B–E). Image collected and cropped by CiteAb from the following open publication (https://link.springer.com/10.1007/s00018-022-04224-2), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Inhibition of mTOR and TGF-beta signaling and leukocyte recruitment by rapamycin during early mitral valve disease in 5-week-old mgR mice.(A) Experimental design: WT and mgR mice were treated with vehicle or rapamycin (RAPA) for 1 week from 4 to 5 weeks of age. Representative IF for (B) number of CD45+ and p-S6+ cells and (C) mean fluorescence density measurement (AU) for p-Smad2 in 5-week-old mice (n = 3–5). Scale bars: 25 μm. Pathway analysis from bulk RNA-Seq in (D) vehicle-treated WT versus mgR mice and (E) vehicle-treated versus rapamycin-treated mgR mice; input genes with adjusted P < 0.05. Data are represented as individual values with mean ± SEM; **P < 0.01, ****P < 0.0001 by 2-way ANOVA. Image collected and cropped by CiteAb from the following open publication (https://www.jci.org/articles/view/183558), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

TGF-beta and mTOR signaling activation and leukocyte accumulation without mitral valve leaflet degenerative changes in 4-week-old mgR mice.(A) Representative Movat pentachrome staining of mitral valve leaflets with maximal leaflet thickness measurement in 4-week-old WT versus mgR mice (n = 6). Scale bar: 100 μm. (B) Morphometric analysis of anterior mitral leaflet area (n = 4). Representative IF and mean fluorescence density measurement (AU) for (C) p-Smad2 and p-S6 (n = 6) and (D) CCL2 and number of CD45+ cells (n = 3). Scale bars: 25 μm. Data are represented as individual values with mean ± SEM; *P < 0.05, ***P < 0.001, ****P < 0.0001 by unpaired t test. Image collected and cropped by CiteAb from the following open publication (https://www.jci.org/articles/view/183558), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Representative scanning electron microscopy and immunofluorescence showed recruitment of different immune cell subsets at CCM lesions in the cerebellum of the Ccm3iECKO mice at P28 for chronic CCM. A Leukocytes are attached to the endothelial cells of CCM lesions in chronic CCM. B-E Cerebellum in Ccm3iECKO mice at P28 in chronic CCM. DAPI staining (blue), together with: (B) MHC class II (green), CD45 (red) and isolectin-B4 (white); (C) Ly6g+ (green), CD45 (red) and isolectin-B4 (white); (D) F4/80 (green), CD45 (red) and isolectin-B4 (white); and (E) CD45R/B220 (red) and CD45 (white). White line in (E) shows the location of the lesions in the cerebellum; white arrows, examples of the immune cell subsets that are positive for both DAPI and CD45. Scale bars: 10 μm (A); 50 μm (B–E). Image collected and cropped by CiteAb from the following open publication (https://link.springer.com/10.1007/s00018-022-04224-2), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunocytochemistry/ Immunofluorescence

Detection of CD45 by Immunocytochemistry/ Immunofluorescence

16-plex PhenoCycler staining of murine FFPE tissues. (A) Table showing the antibodies included in our Murine FFPE PhenoCycler staining panel, and the cell type they are used to identify. (B) Images showing successful PhenoCycler staining of each antibody in the staining panel. In each image, DAPI is blue, and each individual marker is white. The colour of the outer border indicates the tissue type in the image. Scale bar is 50 µM. Image collected and cropped by CiteAb from the following open publication (https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-024…), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of CD45 by Immunohistochemistry

Detection of CD45 by Immunohistochemistry

Activation of the NLRP3 inflammasome in the livers of ICI-treated mice.A (left) Representative western blot from whole liver lysates of treated CTLA4+/- mice for indicated proteins and loading control (GAPDH). (right) Densitometry. B Immunofluorescence for NLRP3 and CD45 on CTLA4+/- liver treated with ICI, and overlay (bottom-right, enlarged in cutout). 40x magnification. Data are mean ± SEM n = 6/group. P-values were calculated using an unpaired t-test. P-value ** (<0.01), *** (<0.001), **** (<0.0001). Image collected and cropped by CiteAb from the following open publication (https://www.nature.com/articles/s41419-024-06535-7), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Mouse CD45 Antibody

Application
Recommended Usage

CyTOF-ready

Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.

Flow Cytometry

2.5 µg/106 cells
Sample: Mouse splenocytes

Immunocytochemistry

5-15 µg/mL
Sample: Immersion fixed RAW 264.7 mouse monocyte/macrophage cell line

Immunohistochemistry

3-15 µg/mL
Sample: Immersion fixed paraffin-embedded sections of mouse liver

Western Blot

0.1 µg/mL
Sample: Recombinant Mouse CD45 (Catalog # 114-CD)

Reviewed Applications

Read 4 reviews rated 4.8 using AF114 in the following applications:

Flow Cytometry Panel Builder

Bio-Techne Knows Flow Cytometry

Save time and reduce costly mistakes by quickly finding compatible reagents using the Panel Builder Tool.

Advanced Features

  • Spectra Viewer - Custom analysis of spectra from multiple fluorochromes
  • Spillover Popups - Visualize the spectra of individual fluorochromes
  • Antigen Density Selector - Match fluorochrome brightness with antigen density
Build Your Panel Now

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.


Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: CD45

Mouse CD45 (also known as Ly5 and leukocyte common antigen) is a 180‑220 kDa variably glycosylated member of the class 1 subtype of the protein tyrosine phosphatase family. It is synthesized as a 1291 amino acid (aa) precursor that contains a 23 aa signal sequence, a 541 aa extracellular domain (ECD), a 22 aa transmembrane segment, and a 705 aa cytoplasmic region. The ECD is coded for by exons 4‑16 of the CD45 gene. Alternate splicing of exon 4 (or A) (aa 30‑74), exon 5 (or B) (aa 75‑123) and exon 6 (or C) (aa 124‑169) define different lymphocyte populations and functional stages. Naïve T cells express exon 5 (CD45 RB), while activated T cells express neither exon 4, 5 or 6 (CD 45 RO). B cells express CD45 RABC, while resting NK cells express CD45 RA. Mouse CD45 ECD shares 60% and 44% aa sequence identity with rat and human full‑length CD45 ECD, respectively.

Long Name

Cluster of Differentiation 45

Alternate Names

CD45, LCA, PTPRC, T200 Glycoprotein

Entrez Gene IDs

5788 (Human); 19264 (Mouse); 490255 (Canine); 100061950 (Equine)

Gene Symbol

PTPRC

UniProt

Additional CD45 Products

Product Documents for Mouse CD45 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

No SDS documents found for this product.

Product Specific Notices for Mouse CD45 Antibody

For research use only

Citations for Mouse CD45 Antibody

Customer Reviews for Mouse CD45 Antibody (4)

4.8 out of 5
4 Customer Ratings
5 Stars
75%
4 Stars
25%
3 Stars
0%
2 Stars
0%
1 Stars
0%

Have you used Mouse CD45 Antibody?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 for a review with an image

$10/€7/£6/$10CAN/¥1110 for a review without an image

Submit a review
Amazon Gift Card

Customer Images


Showing  1 - 4 of 4 reviews Showing All
Filter By:
  • CD45
    Name: Yingjian Li
    Application: Immunofluorescence
    Sample Tested: Liver tissue
    Species: Mouse
    Verified Customer | Posted 06/26/2026
    Immunofluorescence micrograph of ex vivo mouse liver tissue section. Bright green spots show CD45+ cells (AF488 secondary), and blue spots are nuclei (DAPI). Specific signal is clear.
    Used for ex vivo IF staining on mouse liver tissue sections to detect CD45+ cells. Primary antibody (AF114) was diluted at 10 µg/mL and visualized with a 488 secondary antibody.
    Mouse CD45 Antibody AF114
  • Mouse CD45 Antibody
    Name: Anonymous
    Application: Immunocytochemistry/Immunofluorescence
    Sample Tested: Lung tissue
    Species: Mouse
    Verified Customer | Posted 10/05/2023
    DAPI (Blue) CD45 (Yellow)
    Mouse CD45 Antibody AF114
  • Mouse CD45 Antibody
    Name: Anonymous
    Application: Immunohistochemistry
    Sample Tested: retinal faltmounts
    Species: mice
    Verified Customer | Posted 11/08/2022
    Mouse CD45 Antibody AF114
  • Name: Anonymous
    Application: Immunoprecipitation
    Sample Tested: See PMID 22345665
    Species: Other
    Verified Customer | Posted 01/05/2015

There are no reviews that match your criteria.

Showing  1 - 4 of 4 reviews Showing All

Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies